Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Spironolactone plus finasteride reduces hirsutism more effectively.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Trichoscopy is better than trichogram for diagnosing female hair loss.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Minoxidil stimulates hair growth by increasing hair thickness and prolonging growth phase.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Vertex pattern hair loss linked to higher prostate cancer risk.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.